Care of Adults with Advanced Chronic Kidney Disease

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Aug 10

PMID 39124645

Authors

Sanjivani Shrestha

Kanza Haq

Divyanshu Malhotra

Dipal M Patel

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) impacts over 10% of the global population. Adults with CKD face significant morbidity and mortality. As kidney disease progresses, the risk of adverse outcomes increases. Here, we present an overview of strategies to care for adults with advanced CKD (stage 4-5 CKD, not receiving kidney replacement therapy). We aim to guide clinicians through several aspects of CKD care, ranging from recommended laboratory assessments to interdisciplinary support for patients as they plan for kidney replacement therapy (dialysis, transplantation, or conservative management). We incorporate considerations of health equity and person-centered care, empowering clinicians to deliver high-quality care to people with CKD.

References

Verberne W, Dijkers J, Kelder J, Geers A, Jellema W, Vincent H . Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study. BMC Nephrol. 2018; 19(1):205. PMC: 6097302. DOI: 10.1186/s12882-018-1004-4. View

Smekal M, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C . Perceived Benefits and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disease Care: A Qualitative Descriptive Study. Can J Kidney Health Dis. 2018; 5:2054358118763809. PMC: 5888822. DOI: 10.1177/2054358118763809. View

Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D . Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011; 11(10):2093-109. DOI: 10.1111/j.1600-6143.2011.03686.x. View

Grams M, Coresh J, Matsushita K, Ballew S, Sang Y, Surapaneni A . Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA. 2023; 330(13):1266-1277. PMC: 10548311. DOI: 10.1001/jama.2023.17002. View

Bakris G . Slowing nephropathy progression: focus on proteinuria reduction. Clin J Am Soc Nephrol. 2008; 3 Suppl 1:S3-10. PMC: 3152266. DOI: 10.2215/CJN.03250807. View

Ku E, Lee B, McCulloch C, Roll G, Grimes B, Adey D . Racial and Ethnic Disparities in Kidney Transplant Access Within a Theoretical Context of Medical Eligibility. Transplantation. 2019; 104(7):1437-1444. PMC: 7067676. DOI: 10.1097/TP.0000000000002962. View

Young H, Castle E, Briggs J, Walklin C, Billany R, Asgari E . The development and internal pilot trial of a digital physical activity and emotional well-being intervention (Kidney BEAM) for people with chronic kidney disease. Sci Rep. 2024; 14(1):700. PMC: 10771473. DOI: 10.1038/s41598-023-50507-4. View

Hain D, Bednarski D, Cahill M, Dix A, Foote B, Haras M . Iron-Deficiency Anemia in CKD: A Narrative Review for the Kidney Care Team. Kidney Med. 2023; 5(8):100677. PMC: 10319843. DOI: 10.1016/j.xkme.2023.100677. View

Dopp J, Lange A, Maursetter L . Interdisciplinary Telehealth Team Positively Impacts Difficult-to-Control Hypertension in CKD. Kidney360. 2023; 4(6):e817-e823. PMC: 10371363. DOI: 10.34067/KID.0000000000000130. View

10.

Bartlett S, De Leon E, Orbai A, Haque U, Manno R, Ruffing V . Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results. Rheumatology (Oxford). 2019; 59(7):1662-1670. PMC: 7310086. DOI: 10.1093/rheumatology/kez506. View

11.

Lightfoot C, Nair D, Bennett P, Smith A, Griffin A, Warren M . Patient Activation: The Cornerstone of Effective Self-Management in Chronic Kidney Disease?. Kidney Dial. 2023; 2(1):91-105. PMC: 10127536. DOI: 10.3390/kidneydial2010012. View

12.

Bolanos J, Seliger S . Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment: Stuck between a Rock and a Hard Place. Clin J Am Soc Nephrol. 2021; 16(3):345-347. PMC: 8011015. DOI: 10.2215/CJN.00950121. View

13.

Noonan V, Lyddiatt A, Ware P, Jaglal S, Riopelle R, Bingham 3rd C . Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management. J Clin Epidemiol. 2017; 89:125-135. DOI: 10.1016/j.jclinepi.2017.04.017. View

14.

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M . 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18):e895-e1032. DOI: 10.1161/CIR.0000000000001063. View

15.

Meuleman Y, van der Bent Y, Gentenaar L, Caskey F, Bart H, Konijn W . Exploring Patients' Perceptions About Chronic Kidney Disease and Their Treatment: A Qualitative Study. Int J Behav Med. 2023; 31(2):263-275. PMC: 10208195. DOI: 10.1007/s12529-023-10178-x. View

16.

Haley W, Beckrich A, Sayre J, McNeil R, Fumo P, Rao V . Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis. 2014; 65(1):67-79. DOI: 10.1053/j.ajkd.2014.06.031. View

17.

Bhandari S, Allgar V, Lamplugh A, Macdougall I, Kalra P . A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status. BMC Nephrol. 2021; 22(1):115. PMC: 8010943. DOI: 10.1186/s12882-021-02308-y. View

18.

Epstein A, Ayanian J, Keogh J, Noonan S, Armistead N, Cleary P . Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?. N Engl J Med. 2000; 343(21):1537-44, 2 p preceding 1537. PMC: 4598055. DOI: 10.1056/NEJM200011233432106. View

19.

Chan C, Blankestijn P, Dember L, Gallieni M, Harris D, Lok C . Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019; 96(1):37-47. DOI: 10.1016/j.kint.2019.01.017. View

20.

. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial. BMC Med. 2020; 18(1):91. PMC: 7144058. DOI: 10.1186/s12916-020-01542-9. View